𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Dietary iron overload as a risk factor for hepatocellular carcinoma in black africans

✍ Scribed by Eberhard Mandishona; A. Patrick MacPhail; Victor R. Gordeuk; Mary-Anne Kedda; Alan C. Paterson; Tracey A. Rouault; Michael C. Kew


Publisher
John Wiley and Sons
Year
1998
Tongue
English
Weight
65 KB
Volume
27
Category
Article
ISSN
0270-9139

No coin nor oath required. For personal study only.

✦ Synopsis


Although the iron-loading disease, hereditary hemochromatosis, has a strong causal association with hepatocellular carcinoma (HCC), the carcinogenic potential of dietary iron overload in Black Africans is not known. We investigated this potential by evaluating iron status, alcohol consumption, markers for hepatitis B (HBV) and C virus (HCV) infections, and exposure to dietary aflatoxin B 1 in 24 rural patients with this tumor, 48 race-, sex-, and age-matched hospital-based controls, and 75 related or unrelated close family members of the cancer patients. Iron overload was defined as a raised serum ferritin concentration in combination with a transferrin saturation H60%, and was confirmed histologically when possible. Among 24 patients and 48 hospital controls, the risk of developing HCC in the iron-loaded subjects was 10.6 (95% confidence limits of 1.5 and 76.8) relative to individuals with normal iron status, after adjusting for alcohol consumption, chronic HBV and HBC infections, and exposure to aflatoxin B 1 . The risk of HCC in subjects with HBV infection was 33.2 (7.2, 153.4) (odds ratio [95% confidence limits]), HCV infection 6.4 (0.3, 133.5), and alcohol consumption 2.0 (0.5, 8.2). Aflatoxin B 1 exposure did not appear to increase the risk of HCC. The population attributable risk of iron overload in the development of HCC was estimated to be 29%. Among 20 cancer patients and 75 family members, the risk of developing HCC with iron overload was 4.1 (0.5, 32.2). We conclude that dietary iron overload may contribute to the development of HCC in Black Africans. (HEPATOLOGY 1998; 27:1563-1566.) Hepatocellular carcinoma (HCC) is common in southern African Blacks. 1 Chronic hepatitis B (HBV) and C virus Abbreviation: HCC, hepatocellular carcinoma; HCV, hepatitis C virus; HBV, hepatitis B virus.


πŸ“œ SIMILAR VOLUMES


Smoking as a risk factor in hepatocellul
✍ Michel C. Kew; Adrian M. Dibisceglie; Alan C. Paterson πŸ“‚ Article πŸ“… 1985 πŸ› John Wiley and Sons 🌐 English βš– 227 KB πŸ‘ 3 views

Two hundred forty southern African black patients with hepatocellular carcinoma and control subjects matched for race, sex, age, and urban or rural background were questioned about their smoking habits. Patients with hepatocellular carcinoma were not more likely to smoke or to smoke heavily than the

Obesity and diabetes as a risk factor fo
✍ Jean M. Regimbeau; Magali Colombat; Philippe Mognol; FranΓ§ois Durand; Eddie Abda πŸ“‚ Article πŸ“… 2004 πŸ› John Wiley and Sons 🌐 English βš– 76 KB

Ten percent of patients who undergo resection for hepatocellular carcinoma (HCC) associated with chronic liver disease have no detectable cause for this underlying liver disease. Recent studies have shown that patients with cryptogenic chronic liver disease frequently have risk factors for nonalcoho

Postoperative hepatitis status as a sign
✍ Ken Shirabe; Kenji Takenaka; Akinobu Taketomi; Naoyuki Kawahara; Kazuharu Yamamo πŸ“‚ Article πŸ“… 1996 πŸ› John Wiley and Sons 🌐 English βš– 503 KB

## BACKGROUND. Recurrence of small hepatocellular carcinoma (HCC) is common. Recent studies have suggested that the status of the underlying liver parenchyma is a significant risk factor for recurrence of HCC. ## METHODS. The postoperative values of transaminase were examined every 6 months aft

Ultrasound screening and risk factors fo
✍ Tony Hsiu-Hsi Chen; Chien-Jen Chen; Ming-Fang Yen; Sheng-Nan Lu; Chien-An Sun; G πŸ“‚ Article πŸ“… 2002 πŸ› John Wiley and Sons 🌐 French βš– 92 KB

## Abstract Although previous studies have demonstrated the ability of ultrasonography (US) screening to detect small asymptomatic hepatocellular carcinoma (HCC), the efficacy of US screening in reducing deaths from HCC still remained unresolved. A 2‐stage screening program was designed to identify